Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BTS Bioengineering is an Italian healthcare technology and medical device company focused on motion capture, biomechanics, electromyography, gait analysis, and digital rehabilitation solutions for clinical and sports settings. Founded in 1986 as a spin-off of the Polytechnic University of Milan, the company develops proprietary systems used for functional assessment of gait, posture, movement, and muscle activity. Its commercial portfolio includes integrated gait laboratories, wearable gait and balance assessment tools, surface EMG systems, immersive rehabilitation products such as Nirvana, and telerehabilitation software. BTS serves clinicians, rehabilitation centers, researchers, universities, and sports performance users, with operations in Italy and an established U.S. subsidiary. The company is not a drug developer; it is best characterized as a commercial-stage medical device and digital rehabilitation platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BTS Bioengineering.